Advances in Fasciola hepatica research using 'omics' technologies

Area of Science:

• Parasitology
• Veterinary Medicine
• Zoonotic Diseases

Background:

• Fasciola hepatica is a significant livestock parasite and neglected zoonosis globally.
• Triclabendazole is the primary drug for control, but resistance is increasing.
• New strategies are urgently needed due to drug resistance.

Purpose of the Study:

• To review advances in 'omics' technologies for studying liver fluke biology.
• To highlight 'omics' data on host responses to Fasciola hepatica infection.
• To emphasize integrated analyses of host-parasite interactions for drug and vaccine development.

Main Methods:

• Review of technological sequencing advances.
• Analysis of diverse 'omics' datasets (genomics, transcriptomics, proteomics, etc.).
• Integration of parasite and host response datasets.

Main Results:

• 'Omics' technologies enable unbiased analysis of liver fluke biology.
• Extensive datasets on parasite molecules and host responses are now available.
• These datasets facilitate understanding of host-parasite interactions.

Conclusions:

• 'Omics' data provides a foundation for in-depth liver fluke research.
• Integrated host-parasite data analysis is key for future interventions.
• This approach will drive the development of new drugs and vaccines against Fasciola hepatica.